|
related topics |
{stock, price, share} |
{product, liability, claim} |
{product, candidate, development} |
{condition, economic, financial} |
{product, market, service} |
{control, financial, internal} |
{system, service, information} |
{regulation, government, change} |
{personnel, key, retain} |
{acquisition, growth, future} |
{property, intellectual, protect} |
{financial, litigation, operation} |
{stock, price, operating} |
{interest, director, officer} |
{competitive, industry, competition} |
|
We face risks related to general domestic and global economic conditions and to the current credit crisis.
We are a development stage enterprise
We have no assurance that we will be able to develop a commercially feasible product
We will require additional financing and we may not be able to secure the financing necessary to continue our development and operations
We have a history of losses and expect to incur significant losses for the foreseeable future.
We have no assurance that our products will receive market acceptance
We have not conducted a formal market survey
Our officers lack of experience to manufacture or market our products
Our auditors have indicated that our losses raise substantial doubt about our ability to continue a going concern
We are dependent upon certain members of our staff, the loss of which could adversely affect our business.
Certain of the Company s directors and officers are also directors and/or officers and/or shareholders of potential competitors of the Company, giving rise to potential conflicts of interest.
We are dependant upon consultants and outside manufacturing facilities
Our business may suffer if we are unable to adequately protect our intellectual property
Our engines and planned applications may contain product errors which could adversely affect our operations.
Our competition possesses greater technical resources and market recognition than us and there is no assurance that we will be able to compete effectively with these companies.
Market prices for our products may decline in the future which would have a material adverse effect on our business, financial condition and results of operations.
New technology or refinement of existing technology could render our Rand Cam products less attractive or obsolete.
Product liability claims asserted against us in the future could hurt our business.
Our success may be dependent on the timing of new product introductions and lack of market acceptance for our new products.
We may be affected by other factors which may have an adverse effect on our business.
There is only a limited public market for our common shares on the OTC Bulletin and those markets are extremely volatile.
You will be subject to the penny stock rules to the extent our stock price on the OTC Bulletin Board is less than $5.00
You should not expect to receive dividends.
Full 10-K form ▸
|
|
related documents |
816284--2/20/2008--CELGENE_CORP_/DE/ |
3116--3/16/2007--AKORN_INC |
3116--3/17/2008--AKORN_INC |
1041024--3/24/2008--ROCKWELL_MEDICAL_TECHNOLOGIES_INC |
749660--3/23/2010--ICAD_INC |
849636--4/8/2010--CORTEX_PHARMACEUTICALS_INC/DE/ |
857953--4/11/2006--JMAR_TECHNOLOGIES_INC |
1005286--8/4/2009--LANDEC_CORP_\CA\ |
882873--9/17/2010--UROLOGIX_INC |
926763--3/16/2007--ASV_INC_/MN/ |
1036968--3/18/2009--VAXGEN_INC |
1030839--2/13/2007--Synovics_Pharmaceuticals |
749647--3/27/2009--Celsion_CORP |
926763--3/16/2006--ASV_INC_/MN/ |
1068874--10/15/2007--IMPLANT_SCIENCES_CORP |
838879--4/15/2010--RADIENT_PHARMACEUTICALS_Corp |
1005286--8/8/2008--LANDEC_CORP_\CA\ |
849636--3/15/2007--CORTEX_PHARMACEUTICALS_INC/DE/ |
749647--3/17/2010--Celsion_CORP |
1088000--3/28/2006--ESSENTIAL_GROUP_INC |
862668--10/12/2010--ESCALON_MEDICAL_CORP |
749647--3/28/2008--Celsion_CORP |
867840--9/28/2009--PRECISION_OPTICS_CORPORATION_INC |
867840--9/21/2010--PRECISION_OPTICS_CORPORATION_INC |
71478--3/28/2008--LIPID_SCIENCES_INC/ |
1298700--4/15/2009--Verdant_Technology_CORP |
1041024--3/16/2009--ROCKWELL_MEDICAL_TECHNOLOGIES_INC |
1011060--6/28/2006--CARDIOTECH_INTERNATIONAL_INC |
1011060--6/27/2007--CARDIOTECH_INTERNATIONAL_INC |
1078723--3/31/2010--INTERNATIONAL_FUEL_TECHNOLOGY_INC |
|